# Tianjin Weijie Pharmaceutical Co., Ltd. – FDA Inspection, Jan 11, 2018

Source: https://www.keypedia.com/records/fda_inspections/tianjin-weijie-pharmaceutical-co-ltd/eaae5645-8282-4363-8006-5252eec94f8f
Source feed: FDA_Inspections

> FDA inspection 1039729 of Tianjin Weijie Pharmaceutical Co., Ltd., January 11, 2018. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1039729
- Company Name: Tianjin Weijie Pharmaceutical Co., Ltd.
- Inspection Date: 2018-01-11
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1259239 - 2024-11-29
- FDA Inspection 898121 - 2014-09-12
- [FDA Inspection 729423 - 2011-04-30](https://www.keypedia.com/records/fda_inspections/tianjin-weijie-pharmaceutical-co-ltd/1d4ea7d5-4683-4097-85d9-dcd9fec0e604)

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/christopher-t-middendorf/0fea23f5-ffe6-49a0-ac33-780317707c71)

Company: https://www.keypedia.com/companies/tianjin-weijie-pharmaceutical-co-ltd/5316e71b-be46-4ebf-ad94-a862ca6bdf31

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c